N ovel matrix-array technology has been implemented in transesophageal probes recently, allowing real-time 3-dimensional (3D) transesophageal echocardiographic (TEE) imaging. This TEE transducer has been demonstrated to provide superb 3D visualization of posterior cardiovascular structures (eg, mitral valve, interatrial septum, and left atrial appendage); however, data about its usefulness in imaging of patent ductus arteriosus (PDA) are lacking.
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A 71-year-old woman was admitted to the hospital for pulmonary edema. She had a history of arterial hypertension and exertional dyspnea (New York Heart Association class II to III) for Ϸ2 years. A conventional 2-dimensional transthoracic echocardiogram demonstrated left ventricular volume overload, moderate secondary mitral regurgitation, and severe pulmonary hypertension (mean pulmonary artery pressure of 45 mm Hg). Color Doppler flow mapping in the pulmonary trunk revealed continuous flow in the pulmonary trunk, which suggested the presence of a PDA. A large, window-like type of ductus was visualized on the TEE (Figure 1 ; online-only Data Supplement Movie I). Subsequently, the patient underwent elective transcatheter occlu-sion by a 10-mm Amplatzer muscular VSD (ventricular septal defect) occluder (AGA Medical Corp, Golden Valley, Minn). A control aortic angiogram showed a small residual shunt through the mesh of the occluder. Mean pulmonary artery pressure decreased significantly (mean pulmonary artery pressure of 30 mm Hg).
Both 2-dimensional and real-time 3D TEE were performed with a novel matrix-array transducer (X7-2t) and iE33 ultrasound machine (Philips Medical Systems, Andover, Mass). The patient was studied before and after transcatheter closure and at 6-month follow-up. 
